Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Eagle Pharmaceuticals Receives New Patent for Bendeka Configure
Eagle Pharmaceuticals Receives New Patent for Bendeka Configure
Eagle Pharmaceuticals Receives New Patent for Bendeka Configure
Submitted by
admin
on July 3, 2018 - 10:15am
Source:
CP Wire
News Tags:
Eagle Pharmaceuticals
Bendeka
Teva Pharmaceuticals
CLL
patents
Headline:
Eagle Pharmaceuticals Receives New Patent for Bendeka Configure
snippet:
Bendeka has Orphan Drug Exclusivity until Dec. 2022
Company does not expect generic entrants of previous version of Bendeka until Dec. 2022
Teva is responsible for all US commercial activity involving Bendeka
Do Not Allow Advertisers to Use My Personal information
